Key result
Microfluidic nested PCR followed by MiSeq sequencing enabled simultaneous high-throughput detection and genotyping of 11 human pathogenic RNA viruses with a detection limit of 100 to 10^3 copies/µL in cDNA.
This is the authors' abstract. We don't add key points for this paper.
Detection and genotyping of pathogenic RNA viruses in human and environmental samples are useful for monitoring the circulation and prevalence of these pathogens, whereas a conventional PCR assay followed by Sanger sequencing is time-consuming and laborious. The present study aimed to develop a high-throughput detection-and-genotyping tool for 11 human RNA viruses (Aichi virus; astrovirus; enterovirus; norovirus genogroup I [GI], GII, and GIV; hepatitis A virus; hepatitis E virus; rotavirus; sapovirus; and human parechovirus) using a microfluidic device and next-generation sequencer. Microfluidic nested PCR was carried out on a 48.48 Access Array chip, and the amplicons were recovered and used for MiSeq sequencing (Illumina); genotyping was conducted by homology searching and phylogenetic analysis of the obtained sequence reads. The detection limit of the 11 tested viruses ranged from 100 to 103 copies/µL in cDNA sample, corresponding to 101 to 104 copies/mL-sewage, 105 to 108 copies/g-human feces, and 102 to 105 copies/g-digestive tissues of oyster. The developed assay was successfully applied for simultaneous detection and genotyping of RNA viruses to samples of human feces, sewage, and artificially contaminated oysters. Microfluidic nested PCR followed by MiSeq sequencing enables efficient tracking of the fate of multiple RNA viruses in various environments, which is essential for a better understanding of the circulation of human pathogenic RNA viruses in the human population.
Answers are grounded in this paper and cite their sources.
Microfluidic nested PCR followed by MiSeq sequencing enables efficient, high-throughput detection and genotyping of multiple human pathogenic RNA viruses in environmental and clinical samples.
No takes yet. Share an insight, caveat, or question.
Oshiki et al. (2018) studied Human pathogenic RNA viruses. Microfluidic nested PCR and MiSeq amplicon sequencing (MFnPCR-MiSeq) was evaluated on Detection limit and genotyping capability for 11 human RNA viruses. Microfluidic nested PCR followed by MiSeq sequencing enabled simultaneous high-throughput detection and genotyping of 11 human pathogenic RNA viruses with a detection limit of 100 to 10^3 copies/µL in cDNA.
Synapse has enriched 10 related papers. Consider them for comparative context: